text:
EX-99.1
2
lumo-20200727x8kxex991.htm
EXHIBIT 99.1
Exhibit
Exhibit 99.1
Lumos Pharma Announces Sale of Priority Review Voucher
AUSTIN, TX, July 27, 2020 (GLOBE NEWSWIRE) - Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced that it has entered into a definitive agreement to sell its Priority Review Voucher (PRV) to Merck, known as MSD outside the United States and Canada.
The PRV was granted in conjunction with the approval by the U.S. Food and Drug Administration (FDA) of ERVEBO®, a vaccine developed by the Company's licensee, Merck, for the prevention of the Zaire Ebola virus disease. Under the terms of the original license agreement Lumos Pharma is entitled to retain 60% of the value of the PRV. Based upon an agreed valuation of $100 million Merck will pay Lumos $60 million. The transaction remains subject to customary closing conditions, including anti-trust review.
"We are pleased to announce the sale of the PRV, which will provide an important source of non-dilutive capital to fund additional investment in our pipeline and the evaluation of other assets for potential acquisitions or partnerships. These efforts will be critical to our growth over the coming year, and we are committed to our strategic priority of becoming leaders in the rare and ultra-rare disease space", said Rick Hawkins, Chairman, CEO and President. "Additionally, we are looking forward to initiating our Phase 2b trial of our lead candidate LUM-201 in patients with Pediatric Growth Hormone Deficiency, or PGHD, prior to the end of 2020. We believe we have the opportunity to greatly improve the standard of care for patients impacted by this disease. If approved, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment".
Jefferies LLC. acted as exclusive financial advisor to Lumos Pharma, Inc. on this transaction.
Financial Guidance Update Related to PRV Sale
The total valuation of the PRV in the transaction was $100 million, Lumos Pharma will receive approximately $60 million which represents the Company's 60% interest in the total value of the PRV. The $60 million will be received in two non-contingent payments, $34 million in 2020 and $26 million in the first quarter of 2021. The non-dilutive funds from this transaction will provide additional capital to support the expansion of its pipeline through the in-licensing or acquisition of another novel therapeutic candidate for those suffering from rare diseases. These funds are in addition to the Company's cash position as of March 31, 2020 which was anticipated to be sufficient to support the Company's current operations through the Phase 2b clinical trial read-out.
About Lumos Pharma
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding by leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma's lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU. For more information, please visit www.lumos-pharma.com.
Exhibit 99.1
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements of Lumos Pharma, Inc. (the "Company") that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words "forecast", "projected", "guidance", "upcoming", "will", "plan", "intend", "anticipate", "approximate", "expect", "potential", "imminent", or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, the potential of an orally administered treatment regimen for PGHD and other indications, and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that the Company makes due to a number of important factors, including the effects of pandemics or other widespread health problems such as the ongoing COVID-19 pandemic and other risks that could cause actual results to differ materially from those matters expressed in or implied by such forward-looking statements as discussed in "Risk Factors" and elsewhere in Lumos Pharma's definitive proxy statement, as amended and filed with the SEC on February 13, 2020, Lumos Pharma's Annual Report on Form 10-K for the year ended December 31, 2019 and other reports filed with the SEC. The forward-looking statements in this press release represent the Company's views as of the date of this press release. The Company anticipates that subsequent events and developments will cause their views to change. However, while it may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing either of the Company's views as of any date subsequent to the date of this press release.
###
Investor & Media Contact:
Lisa Miller
Lumos Pharma Investor Relations
512-648-3757
ir@lumos-pharma.com

text: Lumos Pharma

text: Priority Review Voucher

text: Lumos Pharma, Inc.

text: Priority Review Voucher

text: Merck

text: Merck

text: Lumos Pharma

text: Merck

text: Rick Hawkins

text: Jefferies LLC.

text: Lumos Pharma, Inc.

text: Lumos Pharma

text: Lumos Pharma

text: Lumos Pharma, Inc.

text: Lumos Pharma

text: Blackstone Life Sciences

text: Roche Venture Fund

text: New Enterprise Associates

text: Santé Ventures

text: Lumos Pharma

text: Lumos Pharma, Inc.

text: Lumos Pharma

text: Lumos Pharma

text: Lumos Pharma


dataset: buster

text:
EX-99.1
4
tat-ex991_10.htm
EX-99.1
tat-ex991_10.htm
Exhibit 99.1
TransAtlantic Petroleum Approval of
Agreement and Plan of Merger
Hamilton, Bermuda (December 18, 2020)
--
TransAtlantic Petroleum Ltd.
(TSX: TNP) (NYSE American: TAT) (the "Company" or "TransAtlantic") today announced that the Company's shareholders have approved the Agreement and Plan of Merger (the "Merger Agreement"), by and among the Company, TAT Holdco LLC, a Texas limited liability company ("Parent"), and TAT Merger Sub LLC, a Texas limited liability company and wholly-owned subsidiary of Parent ("Merger Sub"). Under the Merger Agreement and the Companies Act 1981 of Bermuda (the "Companies Act"), the approval and adoption of the merger proposal required the affirmative vote of 75% of the votes cast by holders of common shares as of the close of business on the record date at a duly convened meeting of the common shareholders of the Company at which a quorum is present. At the meeting, the holders of 56,984,007 Common Shares were represented in person or by proxy, constituting a quorum. Final vote totals indicate that 99.10% of the total votes cast were in favor of the Merger. Of the votes cast by shareholders not affiliated with the Acquiring Group, 86.60% were cast in favor of the Merger.
Pursuant to the Merger Agreement, Company has merged with and into Merger Sub and each of the Company's issued and outstanding common shares, par value $0.10 per share ("Common Shares"), (other than the Excluded Shares (as defined in the Merger Agreement)) was canceled and was converted automatically into the right to receive $0.13 in cash.
The Company closed the transactions contemplated by the Merger Agreement effective at 12:01 am Central Time on December 18, 2020 and the Company's Common Shares were suspended from trading on the NYSE American effective as of the opening of trading on December 18, 2020. The Company expects to be delisted from the NYSE American and Toronto Stock Exchange as soon as practicable.
About TransAtlantic
The Company is an international oil and natural gas company engaged in the acquisition, exploration, development, and production of oil and natural gas. The Company holds interests in developed and undeveloped properties in Turkey and Bulgaria.
(NO STOCK EXCHANGE, SECURITIES COMMISSION, OR OTHER REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE INFORMATION CONTAINED HEREIN.)
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" under the federal securities laws. These forward-looking statements are intended to be covered by the safe harbors created by the Private Securities Litigation Reform Act of 1995. The statements in this report speak only as of the date of hereof, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law.
Contacts:
Christine Stroud
Counsel
214-265-4763
TransAtlantic Petroleum Ltd.
16803 Dallas Parkway
Addison, Texas 75001
http://www.transatlanticpetroleum.com

label: organization

text: TransAtlantic Petroleum Ltd.

text: TAT Holdco LLC

text: TAT Merger Sub LLC

text: TransAtlantic Petroleum Ltd.

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
7
a07-2707_1ex99d1.htm
EX-99.1
Exhibit 99.1
DRAFT FOR
REVIEW
CONTACT
Greg Hughes
Chief Financial Officer
(212) 594-2700
SL Green Realty Corp Completes
Reckson Associates Realty Corp.
Acquisition
New York, NY, January
25, 2007 - SL Green Realty Corp. (NYSE: SLG) announced today the completion of
the previously announced acquisition of Reckson Associates Realty Corp. (NYSE:
RA) in a transaction with a total value of approximately $6.0 billion.
In connection with the
acquisition, SL Green has acquired interests in six premier office buildings in
New York City encompassing approximately 5.6 million square feet. The Company
also acquired approximately 3.6 million square feet of top tier commercial
office space in Westchester and Connecticut and interests in Reckson's RSVP
investment and certain structured finance investments.
Each share of Reckson's
common stock has been converted into the right to receive approximately $31.68
in cash, a prorated dividend in an amount equal to approximately $0.0977 in
cash, and 0.10387 of a share of SL Green common stock. In addition, SL Green
has assumed an aggregate of approximately $238.6 million of Reckson mortgage
debt, approximately $287.5 million of Reckson's convertible debt and
approximately $967.8 million of Reckson's unsecured notes.
Simultaneously
with the closing, SL Green sold certain assets of Reckson to an investment
group led by existing Reckson executive management for a total consideration of
approximately $2.0 billion.
Reckson common stock
was delisted from the New York Stock Exchange effective at the close of
business on January 25, 2007.
About SL Green Realty Corp.
SL Green Realty Corp. is a self-administered and
self-managed real estate investment trust, or REIT, that predominantly
acquires, owns, repositions and manages a portfolio of Manhattan office
properties. As of December 30, 2006 the Company owned 28 office properties
totaling approximately 18.9 million square feet. SL Green's retail ownership
totals approximately 300,000 square feet at eight properties. The Company is the only publicly held REIT
that specializes exclusively in this niche.
To be added to the
Company's distribution list or to obtain the latest news releases and other
Company information, please visit our website at www.slgreen.com or contact
Investor Relations at 212-216-1601.

label: person

text: Greg Hughes

text: SL Green Realty Corp

text: Reckson Associates Realty Corp.

text: SL Green Realty Corp.

text: Reckson Associates Realty Corp.

text: SL Green

override: organization

text: Reckson

text: Reckson

text: SL Green

text: SL Green

text: Reckson

text: Reckson

text: Reckson

text: SL Green

text: Reckson

text: Reckson

text: Reckson

text: SL Green Realty Corp.

text: SL Green Realty Corp.

text: SL Green


text:
EX-99.1
3
dex991.htm
PRESS RELEASE
Press Release
Exhibit 99.1
For More Information, Contact:
Investor
contact:
Varian, Inc.
Investor Relations
650.213.8000, Ext. 3752
ir@varianinc.com
Lauren Lum
Varian, Inc.
650.424.5286
lauren.lum@varianinc.com
VARIAN, INC. COMPLETES ELECTRONICS
MANUFACTURING DIVESTITURE
Varian, Inc. to focus efforts on
Scientific Instruments and Vacuum Technologies businesses; to repurchase shares
PALO ALTO, Calif.
- Varian, Inc. (Nasdaq:VARI) today completed the previously announced sale of its Electronics Manufacturing business to Jabil Circuit, Inc. for $195 million (subject to a post-closing
working capital adjustment). The company announced on February 7, 2005, that it had entered into a definitive agreement with Jabil for the divestiture.
According to Varian, Inc., the sale of the Electronics Manufacturing business will allow the company to advance its overall strategy of growing the
Scientific Instruments and Vacuum Technologies segments by focusing all of its resources on that core business.
The company previously announced that it would initiate repurchases of up to $145 million of its common stock upon successful completion of the
divestiture. That repurchase program is now in effect and replaces a previous authorization to repurchase up to 1,000,000 shares, under which approximately 800,000 shares were repurchased since the company announced the definitive agreement to sell
its Electronics Manufacturing business on February 7, 2005.
About Varian, Inc.
Varian, Inc. is a leading worldwide supplier of scientific instruments and
vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training, and support through its global distribution
system. Varian, Inc. employs approximately 3,500 people and operates manufacturing facilities in 12 locations in North America, Europe, and the Pacific Rim. Varian, Inc. had fiscal year 2004 sales of $724 million (excluding the divested Electronics
Manufacturing segment), and its common stock is traded on Nasdaq under the symbol, "VARI." Further information is available on the company's Web site: www.varianinc.com

text: Varian, Inc.

text: Varian, Inc.

text: VARIAN, INC.

text: Varian, Inc.

text: Varian, Inc.

text: Jabil Circuit, Inc.

text: Varian, Inc.

text: Varian, Inc.

text: Varian, Inc.

text: Varian, Inc.

text: Varian, Inc.


text:
EX-99.1
4
a11-23775_1ex99d1.htm
EX-99.1
Exhibit 99.1
CANTEL MEDICAL CORP.
150 Clove Road
Little Falls, New Jersey 07424
FOR IMMEDIATE RELEASE
Contact:
Andrew A. Krakauer
Richard E. Moyer
President and CEO
Cameron Associates, Inc.
Cantel Medical Corp.
richard@cameronassoc.com
Phone: (973) 890-7220
Phone: (212) 554-5466
CANTEL MEDICAL ACQUIRES
BYRNE MEDICAL, INC., SUBSTANTIALLY INCREASING ITS PRESENCE IN GI ENDOSCOPY
LITTLE FALLS, N.J. - August 2, 2011 - CANTEL MEDICAL CORP. (NYSE:CMN), through its Minntech subsidiary, has acquired the business and substantially all of the assets of Byrne Medical, Inc. Byrne Medical, privately-owned and based outside Houston, TX, designs, manufactures and sells an innovative array of disposable infection control products intended to replace the necessity of sterilizing and reusing numerous components used in gastrointestinal (GI) endoscopy procedures.
For the twelve months ended June 30, 2011, Byrne Medical generated revenues of approximately $38.6 million and pre-tax income of $8.6 million. After adjusting for the shareholders' compensation and other non-recurring expenses, the pre-tax income would be approximately $11.5 million for the twelve-month period. Capitalizing on Byrne Medical's 20%+ historic growth profile, Cantel expects an increase in overall corporate gross margins and anticipates the acquisition to be accretive in Cantel's first fiscal year ending July 31, 2012 (inclusive of the expenses resulting from purchase accounting, financing, and deal-related costs).
The purchase price was $100.0 million, comprised of $90.0 million in cash and 401,123 shares of restricted Cantel stock (valued at $10.0 million) that is subject to a multi-year lock-up and three-year price floor. In addition, there is a contingent earnout of up to $10 million payable over two years based on gross profit growth targets of the acquired business. Cantel will also be purchasing certain land and buildings utilized by the Byrne Medical business for $5.9 million so as to further develop a world-class, disposables manufacturing operation in Houston. The founder and principal owner, Don Byrne, has entered into a three-year employment agreement and separate non-compete agreement.
In purchasing Byrne Medical, Cantel has greatly expanded its hospital and outpatient center-based GI endoscopy business, which includes its market leading Medivators® post-procedure cleaning business. With this acquisition, the company has entered into the
market for infection prevention and control products in the endoscopy procedure room itself. Cantel's collective endoscopy business, with approximately 80 sales consultants and clinical specialists, now offers the GI professional an unparalleled level of expertise and solutions to mitigate infection risks across the full endoscopy procedure cycle.
With the respective mottos of "Infection Control Matters™" and "Dedicated to Infection Prevention and Control", Byrne Medical and Cantel have built their businesses around a shared commitment. Byrne Medical's initial products, the Endo SmartCap® and the EndoGator®, pioneered the movement to disposable alternatives for reusable water bottles and irrigation tube sets used in GI endoscopy procedures. The company now offers an extensive suite of universally applicable infection control solutions including sterile, single-use air/water, suction and biopsy valves.
According to Andrew Krakauer, Cantel Medical's President and CEO, "This is the largest transaction in Cantel's history and clearly an important event. It is very exciting to have two leading endoscopy product businesses as a part of Cantel. Building upon the tremendous growth and momentum in our Medivators endoscope reprocessing segment, Byrne Medical perfectly complements our strategic vision of expanding our presence in the hospital with higher margin, innovative disposables that greatly improve infection prevention and control. We see a growing trend by healthcare providers in GI Endoscopy to minimize risks and reduce the complexities associated with manual cleaning and disinfection of reusable items. The successful debut of our new Medivators endoscope reprocessors and single-use high-level disinfectants, along with the robust demand experienced for the Byrne Medical products, attest to this growing world-wide movement".
Krakauer continued, "I am particularly impressed with Byrne Medical's distinctive understanding of the issues faced by the frontline GI medical personnel and the ability to translate that into ingenious products that solve real problems. Don Byrne has created an outstanding, customer-focused company with great products, excellent manufacturing capabilities, a very effective consultative sales force and an impressive management team".
Don Byrne, President of Byrne Medical commented, "With so many opportunities in our sights, we believe Cantel is the perfect partner to aid us in accelerating our growth plans. There is an excellent cultural fit between our companies, and we share an uncompromising commitment to assist healthcare providers in mitigating infection control risks. I am so proud of what we have accomplished, and I am very thankful to the entire Byrne Medical team. We are all excited to take this business to the next level in our partnership with Cantel and Minntech".
To finance the transaction, Cantel Medical initiated a new, five-year $150.0 million credit facility ($100.0 million revolver and $50.0 million term loan) with its existing syndicate comprised of Bank of America, Wells Fargo and PNC Bank.
In accounting for the transaction, both the $10 million of restricted stock-with-a-floor and the potential $10 million in additional contingent consideration will result in mark-to-
2
market fluctuations in future reported earnings of Cantel Medical. Any such significant movements will be highlighted in the announcement of those results.
The Company will hold a conference call to discuss the acquisition of Byrne Medical on Wednesday, August 3, 2011 at 11:00 AM Eastern time. To participate in the conference call dial (877) 407-8033 or (201) 689-8033 approximately 5 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available through midnight on August 17, 2011 by dialing (877) 660-6853 and using passcode #286 and conference ID # 376814.
The call will simultaneously be broadcast live over the Internet at http://www.investorcalendar.com/IC/CEPage.asp?ID=165439. A replay of the webcast will be available until November 3, 2011.
About Medivators Business Group
Medivators is a Business Group of Minntech Corporation, a subsidiary of Cantel Medical Corp. Minntech, founded in 1974, has its headquarters and major manufacturing operations in Minneapolis, Minnesota. Medivators assists healthcare professionals in minimizing endoscopy-related nosocomial infections through the design, manufacture, and marketing of a comprehensive range of endoscope reprocessing equipment, high-level disinfectants, detergents, flushing aids, neutralizers, leak and fluid detection systems, and a broad array of accessories. For further information, visit the Minntech website at http://www.minntech.com or http://www.medivators.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com.
About Byrne Medical, Inc.
Byrne Medical is fully committed to the pursuit of delivering infection prevention solutions that will reduce potential risks to caregivers and patients in GI Endoscopy. Don Byrne, Founder and President, started the company in 1997 in Conroe, Texas with a single, disposable product and a vision to improve infection control practices. Today, with a full-range of unique product solutions, Byrne Medical has become a recognized leader at the forefront of patient care and safety in GI Endoscopy. Ernst & Young LLP recently honored Don Byrne with the Entrepreneur Of The Year® 2011 Gulf Coast Area
3
Award in the Manufacturing and Distribution category. For further information, visit the Byrne Medical website at http://www.byrnemedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
4

text: CANTEL MEDICAL CORP.

text: Cantel Medical Corp.

text: CANTEL MEDICAL

text: BYRNE MEDICAL, INC.

text: CANTEL MEDICAL CORP.

text: Byrne Medical, Inc.

text: Byrne Medical

text: Byrne Medical

text: Byrne Medical

text: Cantel

text: Cantel

text: Cantel

text: Cantel

text: Byrne Medical

text: Don Byrne

text: Byrne Medical

text: Cantel

text: Cantel

text: Byrne Medical

text: Cantel

text: Byrne Medical

text: Cantel Medical

text: Cantel

text: Cantel

text: Byrne Medical

text: Byrne Medical

text: Byrne Medical

text: Don Byrne

text: Don Byrne

text: Byrne Medical

text: Cantel

text: Byrne Medical

text: Cantel

text: Cantel Medical

text: Cantel Medical

text: Byrne Medical

text: Cantel Medical Corp.

text: Cantel Medical Corp.

text: Cantel Medical Corp.

text: Cantel

text: Byrne Medical, Inc.

text: Byrne Medical

text: Don Byrne

text: Byrne Medical

text: Don Byrne

text: Byrne Medical

text: Cantel


text:
EX-99.1
2
rrd159988_20243.htm
PRESS RELEASE ISSUED BY R.R. DONNELLEY & SONS COMPANY ON MAY 17, 2007
Recipient
Media Contacts: Doug Fitzgerald, Executive Vice President Marketing & Communications Tel: 630-322-6830 E-mail: doug.fitzgerald@rrd.com
Investor Contact: Dan Leib, Senior Vice President - Finance Tel: 312-326-7710 E-mail: dan.leib@rrd.com
Visant
John Sorensen, Vice President, Treasurer Tel: 914-595-8204 E-mail: john.sorensen@visant.net
RR Donnelley Completes Purchase Of Von Hoffmann
CHICAGO, IL and Armonk, NY - May 16, 2007 - R.R. Donnelley & Sons Company (NYSE: RRD) and Visant Corporation
jointly announced today that RR Donnelley's previously announced purchase from Visant Corporation of Von Hoffmann, a
printer of books and other products that serves primarily the education, trade and business-to-business catalog segments, is complete. The $412.5 million acquisition agreement was announced on January 3, 2007.
About RR Donnelley
RR Donnelley (NYSE: RRD) is the world's premier full-service provider of print and related services, including business process outsourcing. Founded more than 140 years ago, the company provides solutions in commercial printing, direct mail, financial printing, print fulfillment, labels, forms, logistics, call centers, transactional print-and-mail, print management, online services, digital photography, color services, and content and database management to customers in the publishing, healthcare, advertising, retail, technology, financial services and many other industries. The largest companies in the world and others rely on RR Donnelley's scale, scope and insight through a comprehensive range of online tools, variable printing services and market-specific solutions. For more information, visit the company's web site at www.rrdonnelley.com.
About Visant
Visant Corporation is a leading marketing and publishing services enterprise servicing the school affinity, direct marketing, fragrance and cosmetics sampling and educational publishing markets. For more information on Visant, please visit the company's web site at www.visant.net.
Use of Forward-Looking Statements
This news release may contain "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements contained in RR Donnelley's filings with the SEC. RR Donnelley disclaims any obligation to update or revise any forward-looking statements.
###

text:
Visant
John Sorensen

text: RR Donnelley

text: Von Hoffmann

text: Visant Corporation

text: RR Donnelley

text: Visant Corporation

text: Von Hoffmann

text: RR Donnelley

text: RR Donnelley

text: RR Donnelley

text: Visant Corporation

text: RR Donnelley

text: RR Donnelley


text:
EX-99.1
2
exhibit991pressrelease.htm
EXHIBIT 99.1
Exhibit
EX - 99.1
The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054
Contacts:
Media
Meg Langan Vice President (973) 290-6319
margaret.langan@themedco.com
Investor Relations Krishna Gorti, M.D. Vice President, Investor Relations
(973) 290-6122 krishna.gorti@themedco.com
FOR IMMEDIATE RELEASE
The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics
PARSIPPANY, N.J. - January 8, 2018 - The Medicines Company (NASDAQ: MDCO) today announced the closing of the sale of its infectious disease business unit to Melinta Therapeutics, Inc. (NASDAQ: MLNT) for consideration consisting of $215 million of guaranteed cash, approximately 3.3 million shares of Melinta common stock, tiered royalty payments of 5% to 25% on worldwide net sales of Vabomere™, Orbactiv® and Minocin® IV, and the assumption by Melinta of all royalty, milestone and other payment obligations relating to those products.
"The sale of our infectious disease business to Melinta Therapeutics successfully completes a crucial step in the Company's strategic evolution, which we initially outlined in late 2015", said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. "The transaction positions the Company to complete the implementation of our previously-announced restructuring and apply our resources to the aggressive development of inclisiran, a first-in-class drug for lowering bad cholesterol (LDL-C). We will now focus on this potentially transformational new treatment option, expecting to make it broadly available to the millions of at-risk, often non-adherent, patients worldwide who carry the potentially deadly and costly risk of high LDL-C. The transaction significantly strengthens the Company's financial position, substantially reduces our cost structure and provides cash and liquidity which we believe will allow us to advance inclisiran through the anticipated completion of the ongoing Phase III development program and clinical data readout in the second half of 2019, and also fund associated manufacturing development as well as the recruitment with initial follow-up of our cardiovascular outcomes trial, without
The Medicines Company
the need to sell equity in the Company. Furthermore, the transaction provides the opportunity to generate significant additional value through a robust royalty structure on future sales of our divested ID products and the ownership of a substantial equity stake in Melinta. That continuing interest reflects our enormous confidence in Melinta and its management team and employees. We are delighted that many of our former infectious disease colleagues have joined Melinta and now have the opportunity to solidify its position as the world's leading, pure-play antibiotics company".
The Company expects to provide additional details regarding its cash position and plans as part of its fourth quarter and full year 2017 financial results.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by an overriding purpose - to save lives, alleviate suffering and contribute to the economics of healthcare. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey.
Forward-Looking Statements
Statements contained in this press release about The Medicines Company that are not purely historical, and all other statements that are not purely historical, may be deemed to be forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "believes", "anticipates" "expects" and "potential" and similar expressions, are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Important factors that may cause or contribute to such differences include the ability of the Company to successfully achieve the expense reduction expected to result from the transaction and restructuring; the commercial success of the infectious disease assets acquired by Melinta; the ability of the Company to effectively develop inclisiran; and such other factors as are set forth in the risk factors detailed in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2017, which are incorporated herein by reference. The Company specifically disclaims any obligation to update these forward-looking statements.

text: The Medicines Company

text: Meg Langan

text: The Medicines Company

text: Infectious Disease Business Unit

text: Melinta Therapeutics

text: The Medicines Company

text: infectious disease business unit

text: Melinta Therapeutics, Inc.

text: Melinta Therapeutics

text: The Medicines Company

text: The Medicines Company

text: The Medicines Company

text: The Medicines Company

text: The Medicines Company


text:
EX-99
2
ex99.txt
EXHIBIT 99
[INTERNATIONAL DISPLAYWORKS, INC. LOGO OMITTED]
International DisplayWorks Completes Acquisition of Three-Five System's Beijing
Manufacturing Facilities and Business
Accelerates Entry into TFT Market and Significantly Expands Customer Base
FOR IMMEDIATE RELEASE
For additional information contact:
Tom Lacey, CEO or Matthew Hayden, President
International DisplayWorks, Inc. Hayden Communications, Inc.
(916) 415-0864 (843) 272-4653
matt@haydenir.com
ROCKLIN, Calif., -- April 13, 2005-- International DisplayWorks, Inc. (Nasdaq:
IDWK), a designer and manufacturer of high-quality liquid crystal displays
(LCDs), modules and assemblies, today announced it has closed the purchase of
the outstanding stock of Three Five System's manufacturing facility and business
in Beijing, China for $8 million in cash, the assumption of $2.4 million in
debt, and an earn-out provision based on two specific revenue targets.
The acquisition is anticipated to provide several benefits to the Company,
including: o Accelerates IDW's revenue growth and the Company's entry into the
TFT business. o Significantly expands the Company's existing product portfolio
for mobile devices.
o Provides IDW access to new customers, including several Fortune 500
companies in the cell phone, industrial, printer and medical device
industries.
o The facility increases revenue production capacity by approximately 35
percent to approximately $700 million overall.
o Provides IDW with an ISO-certified, 56,000 square-foot Beijing
facility, manufacturing equipment, $2 million in qualified inventory,
and a recoverable VAT credit of approximately $675,000. The earn-outs
carry two separate and distinct provisions, and if met will be paid in
IDW common stock valued at the time of issuance. The first earn-out is
predicated upon TFT cell phone display revenues from a specified
customer during the first twelve months and the second is based upon a
combination of TFT and STN displays during the same period. There are
minimum revenue requirements for each of the earnouts, the total
minimum of which equals $84 million.
"We are very pleased to have completed this transaction ahead of schedule and
expect it to be accretive to our earnings per share in the third quarter of our
current fiscal year, and be accretive to cash flow by the first fiscal quarter
of 2006", commented Tom Lacey, IDW's Chairman and Chief Executive Officer. "We
are estimating a cash payback of approximately five to six quarters and revenue
generated will be comprised of approximately 70 percent in TFT displays,
primarily used in cell phones, and approximately 30 percent in STN displays. We
will implement our low-cost SG&A model across this new facility, combining
existing resources with those at our North Campus to improve overall efficiency
and maintain blended gross margins which are in-line with current forecasts in
the low 20 percent range." IDW intends to fund the entire transaction via their
existing credit facility and the cash generated from operations.
About International DisplayWorks
International DisplayWorks, Inc. is a manufacturer and designer of high quality
liquid crystal displays, modules and assemblies for a variety of customer needs
including OEM applications. IDW operates 466,000 square feet of manufacturing
facilities in the People's Republic of China (PRC) and employs approximately
2,900 people. Sales offices are located in US, Europe, Hong Kong, Singapore, and
China. Copies of IDW's 10-K and other documents as filed with the SEC are
available through a link on our web site: www.idwk.com.
NOTE: The foregoing is news relating to International DisplayWorks, Inc. ("IDW")
and contains forward-looking statements, which are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. The
forward-looking statements involve risks and uncertainties that could cause
actual results to differ materially from the forward-looking statements. When
used in this release, the words "anticipate", "believe", "estimate", "expect"
and similar expressions as they relate to IDW or its management, including
without limitation, IDW and its subsidiaries, are intended to identify such
forward-looking statements. IDW's actual results, performance or achievements
could differ materially from the results expressed in, or implied by these
forward-looking statements. For more detailed information the reader is referred
to IDW's 10-K and other related documents filed with the Securities and Exchange
Commission. This does not constitute an offer to buy or sell securities by the
Company and is meant purely for informational purposes.

text: INTERNATIONAL DISPLAYWORKS

text: International DisplayWorks

text: Tom Lacey

text: Matthew Hayden

text: International DisplayWorks

text: International DisplayWorks

text: Tom Lacey

text: International DisplayWorks

text: International DisplayWorks

text: International DisplayWorks


text:
EX-99.2
3
littelfusecompletesacqui.htm
EX-99.2
littelfusecompletesacqui
1 LITTELFUSE COMPLETES ACQUISITION OF CARLING TECHNOLOGIES November 30, 2021
2Littelfuse, Inc. © 2021 DISCLAIMERS Important Information About Littelfuse, Inc. This presentation does not constitute or form part of, and should not be construed as, an offer or solicitation to purchase or sell securities of Littelfuse, Inc. and no investment decision should be made based upon the information provided herein. Littelfuse strongly urges you to review its filings with the Securities and Exchange Commission, which can be found at investor.littelfuse.com/sec.cfm. This website also provides additional information about Littelfuse. "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995. The statements in this presentation that are not historical facts are intended to constitute "forward-looking statements" entitled to the safe-harbor provisions of the Private Securities Litigation Reform Act. These statements may involve risks and uncertainties, including, but not limited to, risks and uncertainties relating to general economic conditions; the severity and duration of the COVID-19 pandemic and the measures taken in response thereto and the effects of those items on the company's business; product demand and market acceptance; the impact of competitive products and pricing; product quality problems or product recalls; capacity and supply difficulties or constraints; coal mining exposures reserves; cybersecurity matters; failure of an indemnification for environmental liability; exchange rate fluctuations; commodity and other raw material price fluctuations; the effect of Littefuse, Inc.'s ("Littelfuse" or the "Company") accounting policies; labor disputes; restructuring costs in excess of expectations; pension plan asset returns less than assumed; integration of acquisitions; uncertainties related to political or regulatory changes; and other risks which may be detailed in the company's Securities and Exchange Commission filings. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, actual results and outcomes may differ materially from those indicated or implied in the forward-looking statements. This presentation should be read in conjunction with information provided in the financial statements appearing in the company's Annual Report on Form 10-K for the year ended December 26, 2020. Further discussion of the risk factors of the company can be found under the caption "Risk Factors" in the company's Annual Report on Form 10-K for the year ended December 26, 2020, and in other filings and submissions with the SEC, each of which are available free of charge on the company's investor relations website at investor.littelfuse.com and on the SEC's website at www.sec.gov. These forward-looking statements are made as of the date hereof. The company does not undertake any obligation to update, amend or clarify these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the availability of new information.
3Littelfuse, Inc. © 2021 CARLING TECHNOLOGIES OVERVIEW  Global leader in switching, circuit protection, & power distribution technologies  Annualized sales of ~$170 million  Strong presence in end markets - Transportation: on/off-highway commercial vehicles & marine - Communications infrastructure: datacom/telecom  Worldwide operations with ~2,800 employees - Primary manufacturing facilities in Mexico, China, & US  Diverse OEM & distributor customer base of 600+
4Littelfuse, Inc. © 2021 Switches Power Distribution Units Circuit Breakers Consistent with strategic M&A priorities ACQUIRED NOVEMBER 2021 NOW PART OF ACQUISITION RATIONALE
5Littelfuse, Inc. © 2021 LITTELFUSE & CARLING TECHNOLOGIES: COMBINATION OF TWO INDUSTRY LEADING BRANDS STRENGTHENS COLLECTIVE MARKET POSITION  Economies of scale to leverage technologies & other investments  Optimization of customer facing & operational structures, leveraging respective strengths  Added operational infrastructure aligned with global customer base Enables Combined Critical Scale Accelerates Growth in Strategic Applications & Markets  Expands addressable market with addition of market leading electromechanical & electronic switching, & circuit breaker technologies  Strengthens engineering, design & test capabilities in switching, controls & software/firmware applications Expansion of Technologies & Capabilities  Significant expansion of in-vehicle electronification in transportation markets:  Commercial vehicles  Heavy-duty truck  Construction  Agriculture  Marine  Strengthened position in 5G telecom, data center & cloud communications infrastructure markets Leverages Complementary Customers & Channels  Expands customer penetration through complementary & new OEM relationships  Significant overlap in global distribution partnerships bolsters position in channel  Increased after-market penetration leveraging Littelfuse relationships

text: LITTELFUSE

text: CARLING TECHNOLOGIES

text: Littelfuse, Inc.

text: Littelfuse, Inc.

text: Littelfuse

text: Littelfuse

text: Littelfuse

text: CARLING TECHNOLOGIES

text: LITTELFUSE

text: CARLING TECHNOLOGIES

text: Littelfuse


text:
EX-99.1
3
a13-17491_1ex99d1.htm
EX-99.1
Exhibit 99.1
ZAZA ENERGY CORPORATION
1301 MCKINNEY STREET
SUITE 2850
HOUSTON, TX 77010
NEWS RELEASE
ZAZA ENERGY CORPORATION ANNOUNCES THE SALE OF
ITS REMAINING MOULTON ASSETS
HOUSTON, TX (July 31, 2013)
- ZaZa Energy Corporation ("ZaZa" or the "Company") (NASDAQ:ZAZA) today announced that it has completed the transaction for the sale of its remaining properties located in Fayette, Gonzalez and Lavaca Counties, Texas, which the Company refers to as its Moulton properties ("Moulton") in the Eagle Ford, to a subsidiary of Sanchez Energy Corporation. After customary closing adjustments and expenses, the net proceeds to ZaZa are ~$29.3 million, for ~10,300 net acres and ZaZa's interest in associated producing wells.
ZaZa intends to use a portion of the net proceeds from the transaction to further reduce its outstanding debt obligations as required under its debt agreements. Pro Forma financial information can be found in the Company's Form 8-K that was filed with the U.S. Securities and Exchange Commission today.
Commenting on today's announcement, Todd A. Brooks, President and Chief Executive Officer of ZaZa stated, "This divestiture provides us with additional working capital and greater financial flexibility as we move through 2013 with a clear objective: Monetize and JV our Eagle Ford West assets in order to improve our balance sheet and build our production base alongside our JV partner in the Eaglebine/Eagle Ford East Play. Progress in this joint venture is continuing as planned and we anticipate timely drilling of the first three wells as part of the Agreement".
About ZaZa Energy Corporation
Headquartered in Houston, Texas, ZaZa Energy Corporation is a publicly-traded exploration and production company with primary assets in the Eagle Ford and Eaglebine/Eagle Ford East resource plays in Texas. More information about the Company may be found at www.zazaenergy.com.
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by words such as "anticipates", "intends", "plans", "seeks", "believes", "estimates", "expects", "forecasts" and similar references to future periods. These statements include, but are not limited to, statements about ZaZa's ability to execute on exploration, production and development plans, estimates of reserves, estimates of production, future commodity prices, exchange rates, interest rates, geological and political risks, drilling risks, product demand, transportation restrictions, actual recoveries of insurance proceeds, the ability of ZaZa to obtain additional capital, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. While forward-looking statements are based on our assumptions and analyses that we believe to be reasonable under the circumstances, whether actual results and developments will meet our expectations and predictions depend on a number of risks and uncertainties that could cause our actual results, performance and financial condition to differ materially from our expectations. See "Risk Factors" in our 2012 Form 10-K and 2013 First Quarter Form 10-Q filed with the Securities and Exchange Commission for a discussion of risk factors that affect our business. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future development, or otherwise, except as may be required by law.
# # #
JMR Worldwide
Jay Morakis, Partner
+1 212-786-6037
jmorakis@jmrww.com
713-595-1900 (OFFICE)
·
713-595-1919 (FAX)
·
WWW.ZAZAENERGY.COM

text: ZAZA ENERGY CORPORATION

text: ZAZA ENERGY CORPORATION

text: ZaZa Energy Corporation

text: Sanchez Energy Corporation

text: Todd A. Brooks

text: ZaZa Energy Corporation

text: ZaZa Energy Corporation

text: Jay Morakis


text:
EX-99.1
3
ex99-1.htm
Exhibit
99.1
DSS
Completes Impact BioMedical Acquisition
August
21, 2020
ROCHESTER,
N.Y., Aug. 21, 2020 (GLOBE NEWSWIRE) - Document Security Systems, Inc. ("DSS" or the "Company")
(NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security,
direct marketing, healthcare, real estate, and securitized digital assets, is pleased to announce the closing of the Company's
acquisition of Impact BioMedical.
"We
are excited to report the official closing of our Impact BioMedical acquisition", stated Frank D. Heuszel, CEO of DSS. "This
transaction is a major milestone for DSS and provides us the opportunity to follow through on our vision of sharing the economic
benefits of our success with our shareholders".
The
Company's long-term plans for Impact BioMedical include taking it public through an initial public offering ("IPO").
As previously announced, in concert with this public offering, DSS anticipates a proposed two-part dividend of Impact BioMedical
shares to its shareholders (except to controlling shareholders of DSS and the Chairman's group of companies), whereby for
every one DSS share of common stock held, the shareholder would be entitled to a bonus of four Impact Shares, the Bonus shares.
The first tranche of the planned Bonus share dividend intends to provide shareholders with two shares of Impact BioMedical for
every share of DSS they hold. The DSS Board of Directors is expected to meet in the immediate future to set a record date for
this tranche. The second tranche of the planned Bonus share dividend is expected to provide an additional two shares of Impact
BioMedical to the DSS shareholders of record on the date of the proposed IPO of Impact BioMedical. The issuance of the Bonus shares
would occur after the registration and the IPO of Impact BioMedical's shares. While there can be no assurance that Impact
BioMedical will be taken public and/or that any Bonus share distribution will occur, particularly due to unforeseen circumstances
including fulfilling the pre-requisite criteria during the IPO application process and market forces beyond the Company's control,
it is the intention of management and the Board to take Impact BioMedical public and to reward DSS shareholders via the issuance
of Bonus shares.
DSS
announced its acquisition of Impact BioMedical in March 2020. Impact BioMedical's ownership of a suite of antiviral and
medical technologies has been valued at $382 million by Destum Partners, known globally for its high level of expertise and capability
in independently valuing and advising on pharmaceutical technology. On May 26, 2020, Impact BioMedical disclosed that it received
a valuation of $933 million for this suite of technology from a different independent valuation firm. Unlike the previous valuation,
the new valuation takes into consideration numerous additional disease applications of the suite of antiviral and medical technologies.
About
Impact BioMedical, Inc.
Impact
BioMedical, Inc. ("Impact BioMedical") is a wholly owned direct subsidiary of Global BioMedical Pte. Ltd., which in
turn is a wholly owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. Impact
BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing
the biomedical field for decades. By tapping into the scientific expertise of GRDG Sciences, LLC, Impact BioMedical pledges to
undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological,
oncological and immuno related diseases. For more information on Impact BioMedical visit
http://impbio.com/
.
About
Document Security Systems, Inc.
DSS
is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing,
healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which
shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves
around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by
its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing
in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value
of $25 billion.
For
more information on DSS visit
http://www.dsssecure.com
.
Investor
Contact:
Dave
Gentry, CEO
RedChip Companies Inc.
407-491-4498
Dave@redchip.com
Safe
Harbor Disclosure
This
press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking
statements include, but are not limited to, statements related to the Company's intended use of proceeds and other statements
that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks
and uncertainties that may cause actual results or events to differ materially from those projected. These risks and uncertainties,
many of which are beyond our control, include: risks relating to our growth strategy; our ability to obtain, perform under and
maintain financing and strategic agreements and relationships; risks relating to the results of development activities; our ability
to attract, integrate and retain key personnel; our need for substantial additional funds; patent and intellectual property matters;
competition; as well as other risks described in the section entitled "Risk Factors" in the prospectus and in our other
filings with the SEC, including, without limitation, our reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC
website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only
as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. We expressly
disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained
herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement
is based, except as required by law.

text: DSS

text: Impact BioMedical

text: Document Security Systems, Inc.

text: DSS

text: DSS

text: Impact BioMedical

text: Impact BioMedical

text: Frank D. Heuszel

text: DSS

text: DSS

text: Impact BioMedical

text: DSS

text: Impact BioMedical

text: DSS

text: DSS

text: Impact BioMedical

text: DSS

text: DSS

text:
Impact
BioMedical

text: DSS

text: Impact BioMedical

text: Impact BioMedical

text:
Impact
BioMedical

text: Impact BioMedical

text: DSS

text: DSS

text: Impact BioMedical

text: Impact BioMedical

text: Impact BioMedical

text: Impact BioMedical

text:
Impact
BioMedical

text: Impact BioMedical

text:
Impact
BioMedical

text: Impact BioMedical

text: Impact BioMedical

text: Document Security Systems, Inc.

text: DSS

text: DSS

text: DSS

text: Fai Chan

text: DSS

text:
Dave
Gentry


text:
EX-99.2
14
d725556dex992.htm
EX-99.2
EX-99.2
Exhibit 99.2
PBF Logistics LP Announces Closing of Initial Public Offering
PARSIPPANY, NJ - May 14, 2014 - PBF Logistics LP (NYSE: PBFX, "PBF Logistics"), a limited partnership formed by subsidiaries of PBF
Energy Inc. (NYSE: PBF, "PBF Energy"), today announced that it has completed its initial public offering of 15,812,500 common units representing limited partner interests, at $23.00 per unit, pursuant to a Registration Statement on Form
S-1 previously filed with the U.S. Securities and Exchange Commission ("SEC"). The number of units issued at closing included 2,062,500 common units issued pursuant to full exercise of the underwriters option to purchase additional common
units. The common units are traded on the New York Stock Exchange under the symbol "PBFX".
Net proceeds received by PBF Logistics from the sale
of the 15,812,500 common units totaled approximately $341.0 million, after deducting the underwriting discount and structuring fee, but before taking into account estimated offering expenses. As of the closing of the offering, the public owns a
49.8% limited partner interest in PBF Logistics. PBF Energy, through certain of its subsidiaries, owns the remaining limited partner interests in PBF Logistics, the non-economic general partner interest and all of the incentive distribution rights.
Barclays and UBS Investment Bank served as joint bookrunners and structuring agents of the offering. Citigroup, Credit Suisse, Deutsche Bank Securities,
Morgan Stanley and Wells Fargo Securities served as joint bookrunners of the offering.
A registration statement on Form S-1 relating to these units has
been filed with, and declared effective by, the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offering of common units will be made only by means of a prospectus. Copies of the final prospectus
related to the offering may be accessed through the SEC's website at
http://www.sec.gov
, or obtained from the offices listed below:
Barclays
Attention: Prospectus Department
c/o Broadridge Financial
Solutions
1155 Long Island Avenue
Edgewood, NY 11717
Toll-free number: (888) 603-5847
Email:
Barclaysprospectus@broadridge.com
UBS Investment Bank
Attention: Prospectus Department
299 Park Avenue
New York, NY 10171
Toll-free number: (888) 827-7275
Citigroup
c/o
Broadridge Financial Solutions
1155 Long Island Avenue
Edgewood, NY 11717
Toll-free number: (800) 831-9146
Email: batprospectusdept@citi.com
Credit Suisse
c/o Prospectus Department
One Madison Avenue, Level B1
New York, NY 10010
Toll-free number: (800) 221-1037
Email: Newyork.prospectus@credit-suisse.com
Deutsche Bank
Securities
Attention: Prospectus Group
60 Wall Street
New York, NY 10005-2836
Toll-free number: (800) 503-4611
Email: prospectus.CPDG@db.com
Morgan Stanley
Attention: Prospectus Dept.
180 Varick Street, 2nd floor
New York, NY 10014
Wells Fargo Securities
Attention: Equity Syndicate Dept.
375 Park Ave.
New York, NY 10152
Toll-free number: (800) 326-5897
Email: cmclientsupport@wellsfargo.com
PBF Logistics LP
PBF Logistics LP, headquartered in Parsippany, New Jersey, is a fee-based, growth-oriented master limited partnership formed by PBF Energy to own or
lease, operate, develop and acquire crude oil and refined petroleum products, terminals, pipelines, storage facilities and similar logistics assets.
FORWARD-LOOKING STATEMENTS
This press
release contains forward-looking statements (as that term is defined under the federal securities laws) made by the company and its management. Such statements are based on current expectations, forecasts and projections, including, but not limited
to, anticipated financial and operating results, plans, objectives, expectations and intentions that are not historical in nature. Forward-looking statements should not be read as a guarantee of future performance or results, and may not necessarily
be accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking statements are based on information available at the time, and are subject to various risks and uncertainties, including the
inability to complete the initial public offering of PBF Logistics, risks relating to the securities markets generally, the impact of adverse market conditions impacting PBF Energy's and/or PBF Logistics' logistics and other assets and
other risks inherent in PBF Energy's and PBF Logistics' business. For more information concerning factors that could cause actual results to differ from those expressed or forecasted, see PBF Energy's annual reports on Form 10-K and
quarterly reports on Form 10-Q and the registration statement on Form S-1 filed by PBF
Logistics with the Securities and Exchange Commission. Forward-looking statements reflect information, facts and circumstances only as of the date they are made. Neither PBF Energy nor PBF
Logistics assumes any responsibility or obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information after such date.
###
Contacts:
Colin Murray (investors)
ir@pbfenergy.com
Tel: 973.455.7578
Michael C. Karlovich (media)
mediarelations@pbfenergy.com
Tel: 973.455.8994

text: PBF Logistics LP

text: PBF Logistics LP

text: PBF Logistics LP

text: PBF Logistics LP


text:
EX-99.1
4
exhibit991pressrelease.htm
EXHIBIT 99.1
Exhibit 99.1 PressRelease
Exhibit 99.1
CONTACT: AT THE COMPANY
Robert McCadden
EVP & CFO
(215) 875-0735
Heather Crowell
VP, Corporate Communications and Investor Relations
(215) 454-1241
crowellh@preit.com
PREIT Completes Acquisition of Springfield Town Center
New property addition accentuates PREIT's portfolio quality
PHILADELPHIA, PA, April 1, 2015 -- PREIT (NYSE: PEI) today announced the closing of its previously-announced acquisition of Springfield Town Center in Springfield, Virginia, a newly-redeveloped 1.35 million square foot premier regional mall. In consideration for the property, PREIT delivered (net of closing credits, adjustments and expenses): (i) $340 million in the form of cash and debt repayment and (ii) 6.25 million units of PREIT's operating partnership, valued on the closing date at $145 million. The cash portion of the purchase price was funded from borrowings under the Company's term loans and revolving credit facility. The acquisition includes the purchase of rights to develop over three million square feet of additional space, and under the deal terms, there is also a potential earn out payable in three years, subject to certain performance conditions.
Among the outstanding new features introduced in October 2014, Springfield Town Center offers a grand entrance lined with restaurants and outdoor dining, a recently redesigned layout enabling better retailer accessibility and visibility, new finishes and unique gathering spaces and amenities. Since the October 14, 2014 tenant roster was released, over 60,000 square feet of new leases have been executed. Nearly 64,000 square feet of tenant space is expected to open for business during the second quarter of 2015 including the eagerly anticipated Nordstrom Rack.
"We are excited to have completed the planned acquisition of Springfield Town Center", said PREIT CEO, Joseph F. Coradino. "The acquisition of this leading mall represents a significant milestone in our portfolio transformation and underscores the tremendous progress we have made in enhancing our high-quality mall portfolio. Since reopening in October, Springfield Town Center has performed extremely well and we are confident that we will be able to further capitalize on the significant opportunities this property offers. The integration of this property bolsters PREIT's premier property platform and we look forward to continuing to execute on our proven strategy to deliver strong returns for our shareholders".
About Pennsylvania Real Estate Investment Trust
PREIT is a real estate investment trust specializing in the ownership and management of differentiated retail shopping malls designed to fit the dynamic communities they serve. Founded in 1960 as Pennsylvania Real Estate Investment Trust, the Company owns and operates over 30 million square feet of space in properties in 12 states in the eastern half of the United States with concentration in the Mid-Atlantic region and Greater Philadelphia. PREIT is headquartered in Philadelphia, Pennsylvania, and is publicly traded on the NYSE under the symbol PEI. Information about the Company can be found at preit.com or on Twitter or LinkedIn.
Exhibit 99.1
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements relate to expectations, beliefs, projections, future plans, strategies, anticipated events, trends and other matters that are not historical facts. These forward-looking statements reflect our current views about future events, achievements or results and are subject to risks, uncertainties and changes in circumstances that might cause future events, achievements or results to differ materially from those expressed or implied by the forward-looking statements. In particular, our business might be materially and adversely affected by uncertainties affecting real estate businesses generally as well as the following, among other factors: our substantial debt and stated value of preferred shares and our high leverage ratio; constraining leverage, unencumbered debt yield, interest and tangible net worth covenants under our 2013 Revolving Facility and our 2014 Term Loans; potential losses on impairment of certain long-lived assets, such as real estate, or of intangible assets, such as goodwill, including such losses that we might be required to record in connection with any dispositions of assets; changes in the retail industry, including consolidation and store closings, particularly among anchor tenants; our ability to sell properties that we seek to dispose of or our ability to obtain prices we seek; the effects of online shopping and other uses of technology on our retail tenants; risks related to development and redevelopment activities; current economic conditions and the state of employment growth and consumer confidence and spending, and the corresponding effects on tenant business performance, prospects, solvency and leasing decisions and on our cash flows, and the value and potential impairment of our properties; our ability to refinance our existing indebtedness when it matures, on favorable terms or at all; our ability to raise capital, including through joint ventures or other partnerships, through sales of properties or interests in properties, through the issuance of equity or equity-related securities if market conditions are favorable, or through other actions; our ability to identify and execute on suitable acquisition opportunities and to integrate acquired properties into our portfolio; our partnerships and joint ventures with third parties to acquire or develop properties; our short- and long-term liquidity position; general economic, financial and political conditions, including credit and capital market conditions, changes in interest rates or unemployment; our ability to maintain and increase property occupancy, sales and rental rates, in light of the relatively high number of leases that have expired or are expiring in the next two years; acts of violence at malls, including our properties, or at other similar spaces, and the potential effect on traffic and sales; changes to our corporate management team and any resulting modifications to our business strategies; increases in operating costs that cannot be passed on to tenants; concentration of our properties in the Mid-Atlantic region; changes in local market conditions, such as the supply of or demand for retail space, or other competitive factors; and potential dilution from any capital raising transactions or other equity issuances. Additional factors that might cause future events, achievements or results to differ materially from those expressed or implied by our forward-looking statements include those discussed in our most recent Annual Report on Form 10-K and in any subsequent Quarterly Report on Form 10-Q in the section entitled "Item 1A. Risk Factors." We do not intend to update or revise any forward-looking statements to reflect new information, future events or otherwise.
###

text: Heather Crowell

text: PREIT

text: PREIT

text: PREIT

text: PREIT

text: PREIT

text: PREIT

text: PREIT

text: PREIT

text: PREIT


text:
EX-99.1
2
pzg_ex991.htm
PRESS RELEASE
pzg_ex991.htm
EXHIBIT 99.1
Paramount Gold and Silver Corp. Closes Acquisition of X-Cal Resources and the Sleeper Gold Project
Winnemucca, Nevada - August 23, 2010
- Further to our press release dated
June 22, 2010
, Paramount Gold and Silver Corp. (NYSE /TSX: PZG) (Frankfurt: WKN: A0HGKQ) ("Paramount") advises that its previously announced acquisition of X-Cal Resources Ltd. (TSX: XCL)("X-Cal") has been approved by 100% of the X-Cal shareholders present or represented by proxy at its recent meeting. The Supreme Court of British Columbia has approved the transaction and the acquisition is now closed.
Christopher Crupi, CEO of Paramount stated, "We are pleased that the shareholders of X-Cal voted in favor of our offer by an overwhelming majority. We feel that we have strengthened our shareholder base, which is a very important aspect of any resource company".
"The combination of Paramount and X-Cal creates an unusually strong base of advanced stage exploration projects with outstanding potential for resource growth in secure jurisdictions, within established mining camps, close to existing producers. The gold exploration business is inherently risky for investors but we believe these risks can be substantially reduced with the right strategy. Our strategy aims to enhance the prospects for investor returns by [1] working in North America only [2] acquiring and expanding deposits that already have defined resources within large-scale geological environments and [3] focusing on projects near producers in established camps where mine-building can be joint-ventured using existing infrastructure", Crupi said.
The main asset of X-Cal is the former Sleeper gold mine in Nevada, a historic open pit mine which was operated by AMAX Gold from 1986 to 1996 when it produced 1.7Moz of Au and 2.3M oz of Ag at an average cash cost of $158/ounce Au. The Sleeper Gold Project is a 30 square mile gold district located in Humboldt County, Nevada. A National Instrument 43-101 resource estimation for the Project was completed by X-Cal in November of 2009 which calculated an indicated resource totaling 750,000 ounces of gold and 5 million ounces of silver [26,960,000 tonnes with a 0.40 gpt Au cutoff, grading 0.87 gpt Au and 5.80 gpt Ag] plus an additional 380,000 ounces of gold and 4.2 million ounces of silver in the inferred category [20,000,000 tonnes with a 0.40 gpt Au cutoff grading 0.59 gpt Au and 6.60 gpt Ag. X-Cal has an extensive database which will help to pursue a series of outstanding exploration targets identified at Sleeper.
1
Other highlights of the combined entity are:
●
Two flagship projects, the San Miguel [northern Mexico] and the Sleeper mine [Nevada] both with National Instrument 43-101 resources and significant additional exploration potential;
●
Experienced personnel poised to aggressively explore and develop its flagship projects;
●
Enhanced market presence with pro forma market capitalization of approximately USD$166 million; and
●
Strong balance sheet and cash position
Shawn Kennedy, former CEO and Director of X-Cal, joined the board of directors of Paramount on closing.
The common shares of X-Cal are expected to be de-listed from the TSX and the company will apply to the relevant securities regulators to cease to be a reporting issuer. Paramount has moved its head office to Nevada on closing.
BNY Mellon will be mailing the letters of transmittals to the X-Cal shareholders on or about August 27, 2010 after which It is expected that the Toronto Stock Exchange ("TSX") will de-list the common shares of X-Cal at the close of business one or two trading days after the mailing. From the time the Arrangement became legally effective and the TSX de-listing of the X-Cal shares, the X-Cal shares represent the appropriate number of Paramount common shares pursuant to the terms of the Arrangement.
Paramount Gold and Silver Corp.
Christopher Crupi, CEO
Chris Theodossiou, Investor Relations
866-481-2233 / 613-226-9881
Cautionary Note to U.S. Investors Concerning Estimates of Indicated and Inferred Resources:
This press release uses the terms "indicated resources" and "inferred resources". We advise U.S. investors that while these terms are defined in and permitted by Canadian regulations, these terms are not defined terms under SEC Industry Guide 7 and are normally not permitted to be used in reports and registration statements filed with the SEC. "Inferred resources" have a great amount of uncertainty as to their existence, and great uncertainty as to their economic and legal feasibility. It cannot be assumed that all or any part of an inferred mineral resource will ever be upgraded to a higher category. Under Canadian rules, estimates of inferred mineral resources may not form the basis of a feasibility study or prefeasibility studies, except in rare cases. The SEC normally only permits issuers to report mineralization that does not constitute SEC Industry Guide 7 compliant "reserves" as in-place tonnage and grade without reference to unit measures. U.S. investors are cautioned not to assume that any part or all of mineral deposits in this category will ever be converted into reserves. U.S. investors are cautioned not to assume that any part or all of an inferred resource exists or is economically or legally minable.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Statements in this document regarding the Transaction, the expected timetable for completing the Transaction, benefits and synergies of the Transaction, future opportunities for the combined company, expectations regarding the value and benefits of the Transaction and any other statements about Paramount or X-Cal managements' future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Any statements that are not statements of historical fact (including statements containing the words "believes", "plans", "anticipates", "expects", estimates and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including, but not limited to: the ability of the parties to consummate the Transaction and satisfy the conditions thereunder; the ability to obtain, and the timing of, the necessary exchange, regulatory and shareholder or stockholder approvals for the Transaction; the impact of any actions taken by any other party to complicate, delay or prevent the Transaction; the ability to realize the anticipated synergies and benefits from the Transaction and the combined company; and the other factors described in Paramount's Annual Report and Annual Information Form on Form 10-K for the year ended June 30, 2009 and its most recent quarterly reports filed with the SEC available on
www.sec.gov
and applicable Canadian securities regulators available on
www.sedar.com
and X-Cal's filings with the applicable Canadian securities regulators available on
www.sedar.com
. Except as required by applicable law, each of Paramount and X-Cal disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this document.
2

text: Paramount Gold and Silver Corp.

text: X-Cal Resources

text: Paramount Gold and Silver Corp.

text: X-Cal Resources Ltd.

text: Christopher Crupi

text: Paramount Gold and Silver Corp.

text: Christopher Crupi


text:
EX-99.1
2
exhibit991pressreleasetimb.htm
PRESS RELEASE
Exhibit 99.1 Press Release Timberland Acquisition Q4 2011
Exhibit 99.1
News Release
Contacts
Investors
Carl Kraus
904-357-9158
Media
Robin Keegan
904-357-9194
Rayonier Completes Acquisition of 250,000 Acres
JACKSONVILLE, Fla., Nov. 29, 2011 - Rayonier (NYSE: RYN) completed the previously announced acquisition of approximately 250,000 acres of timberlands from Joshua Timberlands LLC and Oklahoma Timber, LLC for $330 million. The acquisition was funded using cash, Rayonier's revolving credit facility and the assumption of existing debt of the sellers.
"The acquisition of these quality timberlands aligns with our strategy to grow and diversify Rayonier's timberland ownership", said Lee M. Thomas, chairman and chief executive officer.
The timberlands are located primarily in Mississippi, Louisiana, Oklahoma and Alabama. With the completion of the acquisition, Rayonier now owns, leases or manages approximately 2.7 million acres in ten states in the U.S., and New Zealand.
About Rayonier
Rayonier is a leading international forest products company with three core businesses: Forest Resources, Real Estate and Performance Fibers. The company owns, leases or manages 2.7 million acres of timber and land in the United States and New Zealand. The company's holdings include approximately 200,000 acres with residential and commercial development potential along the Interstate 95 corridor between Savannah, Ga., and Daytona Beach, Fla. Its Performance Fibers business is one of the world's leading producers of high-value specialty cellulose fibers, which are used in products such as filters, pharmaceuticals and LCD screens. Approximately 45 percent of the company's sales are outside the U.S. to customers in approximately 40 countries. Rayonier is structured as a real estate investment trust. More information is available at www.rayonier.com.
# # #
1301 Riverplace Blvd., Jacksonville, FL 32207
904-357-9100

text: Rayonier

text: Rayonier

text: Joshua Timberlands LLC

text: Oklahoma Timber, LLC

text: Rayonier

text: Rayonier

text: Lee M. Thomas

text: Rayonier

text: Rayonier

text: Rayonier

text: Rayonier


text:
EX-99
3
hme8k06302006ex991.htm
NEWS RELEASE 6/29/2006
EXHIBIT 99.1
FOR IMMEDIATE RELEASE
HOME PROPERTIES COMPLETES SALE OF
SOUTHEAST MICHIGAN PORTFOLIO
Company Repurchases Common Shares and Purchases Two Properties
ROCHESTER, NY, JUNE 29, 2006 -- Home Properties, Inc. (NYSE:HME) today announced
completion of the sale of its entire portfolio of 19 properties containing 5,046
apartment units in the Detroit, Michigan area for total consideration of $230
million, or approximately $45,600 per unit, to the Lakewood, New Jersey-based
Lightstone Group. Net proceeds to Home Properties, after closing costs and $72.7
million in debt repayments, were $150.4 million. The weighted average first year
capitalization rate on the sale is 7.6% after applying a 3% management fee and
after a $300 per unit reserve for capital expenditures. Any gain or loss, which
is estimated to be close to breakeven, will be recorded in the 2006 second
quarter. In addition, interest expense reported in discontinued operations will
include approximately $3 million of prepayment penalties and unamortized loan
acquisition costs triggered by the loan payoffs upon sale. Neither the gain
(loss) nor the interest costs will be included in the Company's reported Funds
from Operations for the second quarter of 2006.
"Home Properties' exit from the Michigan market is consistent with our strategy
of focusing our operations in high barrier, high growth markets along the East
Coast", said Edward J. Pettinella, Home Properties' President and CEO. "The sale
of the Detroit portfolio will improve the Company's future financial
performance, which was muted in recent years by the negative net operating
income growth of these properties".
In 2005, year-over-year net operating income (NOI) growth for the Detroit-area
properties was negative 9.8%. For the first quarter of 2006 compared to the
first quarter of 2005, NOI growth was negative 5.2%. During these same periods,
rental rate and rental revenue growth for the Detroit properties also were
negative. In the first quarter of 2006, the Detroit properties produced 7.1% of
Home Properties' net operating income and comprised 11.6% of the total apartment
units owned by the Company.
In earnings guidance presented during its fourth quarter 2005 conference call,
the Company said it had assumed a gross purchase price of $240 million for the
Detroit portfolio with net proceeds from the sale of $153.7 million. At the
actual $230 million purchase price, net proceeds were $150.4 million due to $6.7
million less in closing costs than had been estimated previously. Home
Properties continues to expect the sale and ultimate use of proceeds will be
seven cents per share dilutive in 2006, identical to previously published
guidance.
The Company said it expects to use approximately $77 million of the net proceeds
for common share repurchase and the balance for property acquisitions in the
Company's targeted East Coast markets. From May 19, 2006 to June 20, 2006, in
anticipation of the closing of the Detroit property sale, Home Properties
repurchased 1,572,721 shares at a weighted average price of $50.87 per share or
a total of $80.0 million. The Company has Board authorization to buy back up to
approximately 1.5 million additional shares of its common stock or Operating
Partnership Units.
Also in anticipation of the Detroit sale, the Company recently completed two
acquisitions in the Boston, Massachusetts suburb of Randolph, which is
approximately 12 miles south of downtown Boston.
Highland House (172 units) was purchased on May 31, 2006 for $17.9 million,
including closing costs, which equates to approximately $104,000 per unit. The
transaction consisted of assumption of a mortgage of $6.3 million at 6.99%
maturing on January 1, 2029. The balance was funded through the Company's line
of credit. Built between 1965 and 1969, Highland House is 94.7% occupied with
monthly rents averaging $1,077. The property has four three-story buildings and
one four-story building. Buildings are of wood frame construction on poured
concrete slab foundations with brick exteriors and pitched, asphalt-shingled
roofs. The unit mix consists of 26 studio, 73 one-bedroom and 73 two-bedroom
apartments. The average apartment size is 764 square feet. Highland House has
natural gas-fired baseboard heat from boilers, sleeve air conditioning units in
each apartment and individually metered electric service. Amenities include an
outdoor swimming pool, tennis court and fitness center.
During the first few years of ownership, the Company expects to spend a total of
approximately $1.1 million in improvements to correct deferred replacements,
repair the parking lot, improve signage and landscaping, and upgrade kitchens
and baths. Management anticipates a 6.3% weighted average first year
capitalization rate on this acquisition. (The return is calculated after
allocating 3.0% of rental revenues for management and overhead expenses and
before normalized capital expenditures of approximately $525 per unit annually.)
Liberty Place (107 units) was purchased on June 6, 2006 for a total purchase
price of $14.9 million, including closing costs, which equates to approximately
$139,000 per apartment unit. Consideration included the assumption of a $6.2
million mortgage at an interest rate of 6.79%, maturing on November 1, 2012. The
balance was funded through the Company's line of credit. The property is
currently 93.0% occupied with monthly rents averaging $1,368.
Built in 1988, the property consists of twelve three-story buildings with
elevators. Buildings are of wood frame construction on poured concrete slabs
with vinyl and wood exteriors. Roofs are pitched with asphalt shingles. The unit
mix consists of 12 one-bedroom and 84 two-bedroom apartments and 11
three-bedroom townhouse units. Each unit has a natural gas-fired forced hot air
furnace, a hot water tank, electric central air conditioning and individually
metered electric service. There is a laundry room in each building. The average
apartment size is 972 square feet. Amenities include a clubhouse with fitness
center, an outdoor swimming pool and a tennis court.
During the first few years of ownership, the Company expects to spend a total of
approximately $1.0 million in improvements to correct deferred replacements,
repair and clean building exteriors, repair the parking lot, improve signage and
landscaping, and upgrade kitchens and baths. Management anticipates a 6.6%
weighted average first year capitalization rate.
With the two Randolph, Massachusetts acquisitions, Home Properties owns a total
of five properties with 1,531 units in the Boston, Massachusetts suburbs.
This press release contains forward-looking statements. Although the Company
believes expectations reflected in such forward-looking statements are based on
reasonable assumptions, it can give no assurance that its expectations will be
achieved. Factors that may cause actual results to differ include general
economic and local real estate conditions, the weather and other conditions that
might affect operating expenses, the timely completion of repositioning
activities within anticipated budgets, the actual pace of future acquisitions
and dispositions, and continued access to capital to fund growth.
Home Properties is a publicly traded apartment real estate investment trust that
owns, operates, acquires and rehabilitates apartment communities primarily in
selected Northeast, Mid-Atlantic and Southeast Florida markets. Currently, Home
Properties operates 139 communities containing 42,146 apartment units. Of these,
38,577 units in 134 communities are owned directly by the Company; 868 units are
partially owned and managed by the Company as general partner, and 2,701 units
are managed for other owners. For more information, visit Home Properties' Web
site at www.homeproperties.com.
###
For further information:
------------------------
David P. Gardner, Executive Vice President and Chief Financial Officer, (585)
246-4113
Charis W. Warshof, Vice President, Investor Relations, (585) 295-4237

text: HOME PROPERTIES

text: Home Properties, Inc.

text: Home Properties

text: Home Properties

text: Home Properties

text: Home Properties

text:
Home
Properties

text: Home Properties

text: Home Properties

text: Home Properties

text:
Home
Properties

text: Home Properties

text: Charis W. Warshof


text:
EX-99.1
17
exh99-1_1811261.htm
PRESS RELEASE
exh99-1_1811261.htm
EXHIBIT 99.1
Inteliquent Contact
GTT Contact
Darren Burgener
Michelle Reilly
(312) 380-4548
(703) 442-5582
Inteliquent Sells Global Data Business to GTT for $54.5 Million
Chicago, IL and McLean, VA, April 30, 2013 - Neutral Tandem, Inc. d/b/a
Inteliquent (NASDAQ: IQNT) announced today that it has sold its global data services business to
GTT
(OTCQB: GTLT) for $54.5 million. The transaction consideration includes $52.5 million of cash and $2.0 million of commercial services that GTT will provide to Inteliquent over three years. The transaction signed and closed on April 30, 2013.
The global data business sold by Inteliquent generated revenues of $69.5 million in 2012 and serves over 1,100 customers. The data business has over 120 points of presence in 24 countries and provides IP Transit and Ethernet services. The data business is one of the largest global Ethernet interconnection networks, a top-five global IP Transit service provider and a leading IPv6 network. The data business is largely comprised of the assets acquired by Inteliquent through its purchase of Tinet S.p.A. in 2010.
Ed Evans, Chief Executive Officer of Inteliquent, stated, "We are pleased to conclude the sale of our data business. We look forward to working to grow our core voice services business, to which we will dedicate all of our efforts going forward. This transaction also affords us with significant balance sheet flexibility to consider other value-enhancing alternatives for our shareholders".
Richard D. Calder Jr., President and Chief Executive Officer of GTT, stated, "Acquiring the Inteliquent data business accelerates our established growth curve towards becoming a more asset-based network solution provider, capable of delivering complex, integrated network solutions globally".
Inteliquent was advised by BMO Capital Markets and Simpson Thacher & Bartlett LLP. GTT was advised by Bank Street Group and Kelley Drye & Warren LLP.
About Inteliquent
Headquartered in Chicago, Inteliquent provides intelligent networking to solve challenging voice interconnection and interoperability issues. With an advanced MPLS network that is highly interconnected to major carriers and service providers, Inteliquent serves its voice customers worldwide. Please visit Inteliquent's website at www.inteliquent.com and follow us on Twitter@Inteliquent.
About GTT
GTT is the premiere cloud network provider to the world. Powered by our global Ethernet and IP backbone, GTT operates the most interconnected network on the globe. With 15 years of proven experience, GTT delivers simplicity, speed and agility, with an absolute client focus. For more information visit the GTT website at
www.gt-t.net
.
Inteliquent Cautionary Statement Regarding Forward-Looking Statements
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements, other than statements of historical fact, included in this press release by Neutral Tandem, Inc. d/b/a Inteliquent (the "Company") are forward-looking statements. The words "anticipates", "believes", "efforts", "expects", "estimates", "projects", "proposed", "plans", "intends", "may", "will", "would", and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Company makes. Factors that might cause such differences include, but are not limited to: any adjustment to the purchase price pursuant to the terms of the purchase agreement between GTT and the Company; any business disruption associated with the Company's sale of the data business, including disruptions regarding separating the Company's network, IT and billing systems from the network and systems sold to GTT, and that the cost savings and other benefits the Company expects to receive may not materialize in part or at all; the Company's ability to maintain relationships with business providers following the sale of the data business; and other important factors included in the Company's reports filed with the Securities and Exchange Commission (the "SEC"),
particularly in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the period ended December 31, 2012, as such Risk Factors may be updated from time to time in subsequent reports. Furthermore, such forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.
Additional Information and Where to Find It
In connection with the proxy contest initiated by Clinton Magnolia Master Fund, Ltd., the Company will be filing a definitive proxy statement and accompanying WHITE proxy card with the SEC in connection with the solicitation of proxies for its 2013 annual meeting of stockholders. Stockholders are strongly advised to read the Company's 2013 definitive proxy statement when it becomes available because it will contain important information. Stockholders will be able to obtain copies of the Company's 2013 definitive proxy statement and other documents filed by the Company with the SEC in connection with its 2013 annual meeting of stockholders at the SEC's website at www.sec.gov or at the "Investor Relations" section of the Company's website at ir.inteliquent.com.
Participants in the Solicitation
The Company, its directors, its executive officers, and certain other members of management and employees of the Company may be deemed "participants" in the solicitation of proxies from stockholders of the Company in connection with the matters to be considered at the 2013 annual meeting of stockholders. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of the stockholders of the Company in connection with such matters is set forth in the preliminary proxy statement filed with the SEC on April 19, 2013 and will be set forth in the definitive proxy statement to be filed with the SEC.

text: Inteliquent

text: GTT

text: Inteliquent

text: GTT

text: Inteliquent

text: GTT

text: GTT

text: Inteliquent

text: Inteliquent

text: Inteliquent

text: Ed Evans

text: Inteliquent

text: GTT

text: Inteliquent

text: Inteliquent

text: BMO Capital Markets

text: Simpson Thacher & Bartlett LLP

text: GTT

text: Bank Street Group

text: Kelley Drye & Warren LLP

text: Inteliquent

text: Inteliquent

text: Inteliquent

text: Inteliquent

text: GTT

text: GTT

text: GTT

text: GTT

text: GTT

text: Inteliquent

text: Inteliquent

text: GTT

text: GTT


text:
EX-99.2
3
ex_99-2.htm
Exhibit 99.2
Sovran Self Storage, Inc.
6467 Main St., Buffalo, NY 14221
(716) 633-1850
FOR IMMEDIATE RELEASE
July 18, 2016
Sovran Self Storage, Inc. to Rebrand as Life Storage
®
Buffalo, New York
, July 18, 2016 - Sovran Self Storage, Inc., (NYSE:SSS), a self storage real estate investment trust (REIT), announced today that it will rebrand the 563 storage facilities it presently operates as "Uncle Bob's Self Storage
®
" to "Life Storage
®
". The Company also plans to change its corporate name from "Sovran Self Storage, Inc." to "Life Storage, Inc." and its ticker symbol on the New York Stock Exchange from SSS to LSI. These changes are expected to occur in mid-August, 2016.
"Life Storage is the perfect brand name for our Company and for our stores", said David Rogers, Chief Executive Officer. "Our customers see us as an extension of their homes or businesses, where the environment is welcoming and their belongings are secure. We've always operated with that in mind, but the Life Storage name brings it into focus - it's about the customer, not about us".
A rebranded Life Storage website - set to launch the week of August 8, 2016 - will depict the new Life Storage logo and feature the recently acquired 84 facilities originally branded as Life Storage. It is expected that the cost of the rebranding, which primarily relates to replacement signage at each store and rewrapping the Company's fleet of rental trucks, will be approximately $22 million.
The rebranding of the existing Uncle Bob's Self Storage locations will commence in August and continue on a market-by-market basis into the second quarter of 2017. As signs change and rebranding occurs in each area, the converted stores will be added to the Life Storage website. The existing website
www.unclebobs.com
will remain in operation until all stores are converted.
About Sovran Self Storage, Inc.
Sovran Self Storage, Inc. is an equity REIT that is in the business of acquiring and managing self storage facilities. The Company operates approximately 650 self storage facilities in 29 states. For more information, visit
www.unclebobs.com/company
.

text: Sovran Self Storage, Inc.

text: Sovran Self Storage, Inc.

text: Life Storage

text: Sovran Self Storage, Inc.

text: Life Storage

text: Sovran Self Storage, Inc.

text: Life Storage

text: Life Storage

text: David Rogers

text: Life Storage

text: Life Storage

text: Life Storage

text: Life Storage

text: Life Storage

text: Sovran Self Storage, Inc.

text: Sovran Self Storage, Inc.